Fullerenol: A new nanopharmaceutic (original) (raw)

This paper discusses fullerenes, a unique crystalline form of carbon, specifically focusing on fullerene derivative fullerenol (C60(OH)n). Fullerenol, modified by hydroxyl groups, presents promising biological activity, including strong antioxidative properties and radiopharmaceutical applications, with investigations revealing its biodistribution and potential cardioprotective effects. The findings suggest fullerenol may become a significant nanoparticle in future pharmaceuticals, pending further research on its pharmacokinetics and mechanisms of action.